WHO ICTRP trial

PRIMROSE Audit: A multicentre audit of care provided to patients with breast…

ISRCTN18204314 · International Standard Randomised Controlled Trial Number (ISRCTN) · Recruiting

Key facts

Trial ID ISRCTN18204314
Public title PRIMROSE Audit: A multicentre audit of care provided to patients with breast cancer involving the brain in the UK
Scientific title PRIMROSE Audit: A Prospective Multi-Centre Project to Assess the Presentation, Management, and Outcomes of Patients with CNS Disease Secondary to Breast Cancer
Primary sponsor University of Liverpool
Registry International Standard Randomised Controlled Trial Number (ISRCTN)
Recruitment status Recruiting
Study type Observational
Phase Not Applicable
Countries United Kingdom
Conditions Central Nervous System disease secondary to breast cancer Cancer
Interventions Patients' records will be reviewed to collect routine care data on demographic information, clinicopathological features and treatment of primary breast cancer, information relating to disease recurrence, prior cancer treatment for non-CNS…
Registration date Aug 19, 2020
Target size 100
Secondary IDs Nil known;Nil known;Nil known
Registry page isrctn.com

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations